Multidisciplinary treatment of desmoid tumours in Gardner's syndrome due to a large interstitial deletion of chromosome 5q

QJM: An International Journal of Medicine

Volumn 107, Issue 7, 2014, Pages 521-527

  Casper, M ^a   Petek, E ^b   Henn, W ^a   Niewald, M ^a   Schneider, G ^a   Zimmer, V ^a   Lammert, F ^a   Raedle, J ^c  

^a SAARLAND UNIVERSITY   (Germany)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

^c Westpfalz Hospital   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOMATOUS POLYP; ADULT; ARTICLE; BODY DYSMORPHIC DISORDER; CANCER RADIOTHERAPY; CANCER SURGERY; CASE REPORT; CHROMOSOME 5Q; COMPARATIVE GENOMIC HYBRIDIZATION; DESMOID TUMOR; FEMALE; GARDNER SYNDROME; HUMAN; ILEOSTOMY; INTERSTITIAL CHROMOSOME DELETION; MENTAL DEFICIENCY; MULTIMODALITY CANCER THERAPY; PHARMACEUTICAL CARE; PRIORITY JOURNAL; PROCTOCOLECTOMY; RADIOTHERAPY; TERTIARY CARE CENTER; ABDOMINAL NEOPLASMS; ADENOMATOUS POLYPOSIS COLI; CHROMOSOME 5; CHROMOSOME DELETION; FACIES; FIBROMATOSIS, AGGRESSIVE; GENETICS; NUCLEAR MAGNETIC RESONANCE IMAGING;

ABDOMINAL NEOPLASMS; ADENOMATOUS POLYPOSIS COLI; ADULT; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 5; COMBINED MODALITY THERAPY; COMPARATIVE GENOMIC HYBRIDIZATION; FACIES; FEMALE; FIBROMATOSIS, AGGRESSIVE; GARDNER SYNDROME; HUMANS; MAGNETIC RESONANCE IMAGING;

EID: 84903761903     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcu036     Document Type: Article

References (32)

1. Half E, Bercovich D, Rozen P. Familial adenomatous polyposis. Orphanet J Rare Dis 2009; 4:22.
2. Groden J, Thliveris A, Samowitz W, Carlson M, Gelbert L, Albertsen H, et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 1991; 66:589-600.
3. Bisgaard ML, Fenger K, Bülow S, Niebuhr E, Mohr J. Familial adenomatous polyposis (FAP): frequency, penetrance, and mutation rate. Hum Mutat 1994; 3:121-5.
4. Michils G, Tejpar S, Thoelen R, van Cutsem E, Vermeesch JR, Fryns JP, et al. Large deletions of the APC gene in 15% of mutation-negative patients with classical polyposis (FAP): a Belgian study. Hum Mutat 2005; 25:125-34.
5. Aretz S, Stienen D, Uhlhaas S, Pagenstecher C, Mangold E, Caspari R, et al. Large submicroscopic genomic APC deletions are a common cause of typical familial adenomatous polyposis. J Med Genet 2005; 42:185-92.
6. Gardner EJ, Richards RC. Multiple cutaneous and sub-cutaneous lesions occurring simultaneously with hereditary polyposis and osteomatosis. Am J Hum Genet 1952; 5:139-47.
7. Spigelman AD, Williams CB, Talbot IC, Domizio P, Phillips RK. Upper gastrointestinal cancer in patients with familial adenomatous polyposis. Lancet 1989; 2:783-5.
8. Escobar C, Munker R, Thomas JO, Li BD, Burton GV. Update on desmoid tumors. Ann Oncol 2012; 23:562-9.
9. Sieber OM, Lamlum H, Crabtree MD, Rowan AJ, Barclay E, Lipton L, et al. Whole-gene APC deletions cause classical familial adenomatous polyposis, but not attenuated polyposis or ''multiple'' colorectal adenomas. Proc Natl Acad Sci U S A 2002; 99:2954-8.
10. Nielsen M, Bik E, Hes FJ, Breuning MH, Vasen HF, Bakker E, et al. Genotype-phenotype correlations in 19 Dutch cases with APC gene deletions and a literature review. Eur J Hum Genet 2007; 15:1034-42.
11. Garcia-Miñaur S, Ramsay J, Grace E, Minns RA, Myles LM, FitzPatrick DR. Interstitial deletion of the long arm of chromosome 5 in a boy with multiple congenital anomalies and mental retardation: molecular characterization of the deleted region to 5q22.3q23.3. Am J Med Genet A 2005; 132:402-10.
12. Ofner L, Raedle J, Windpassinger C, Schwarzbraun T, Kroisel PM, Wagner K, et al. Phenotypic and molecular characterisation of a de novo 5q deletion that includes the APC gene. J Hum Genet 2006; 51:141-6.
13. Tzschach A, Krause-Plonka I, Menzel C, Kalscheuer V, Toennies H, Scherthan H, et al. Molecular cytogenetic analysis of a de novo interstitial deletion of 5q23.3q31.2 and its phenotypic consequences. Am J Med Genet A 2006; 140:496-502.
14. Lee S, Chae H, Park IY, Kim M, Kim Y, Shin JC, et al. Genotype-phenotype correlation of a 5q22.3 deletion associated with craniofacial and limb defects. Gene 2012; 494:105-8.
15. Cross I, Delhanty J, Chapman P, Kim M, Kim Y, Shin JC, et al. An intrachromosomal insertion causing 5q22 deletion and familial adenomatous polyposis coli in two generations. J Med Genet 1992; 29:175-9.
16. Lindgren V, Bryke CR, Ozcelik T, Yang-Feng TL, Francke U. Phenotypic, cytogenetic, and molecular studies of three patients with constitutional deletions of chromosome 5 in the region of the gene for familial adenomatous polyposis. Am J Hum Genet 1992; 50:988-97.
17. Hodgson SV, Coonar AS, Hanson PJ, Cottrell S, Scriven PN, Jones T, et al. Two cases of 5q deletions in patients with familial adenomatous polyposis: possible link with Caroli's disease. J Med Genet 1993; 30:369-75.
18. Barber JC, Ellis KH, Bowles LV, Delhanty JD, Ede RF, Male BM, et al. Adenomatous polyposis coli and a cytogenetic deletion of chromosome 5 resulting from a maternal intrachromosomal insertion. J Med Genet 1994; 31:312-6.
19. Bennett RL, Karayiorgou M, Sobin CA, Norwood TH, Kay MA. Identification of an interstitial deletion in an adult female with schizophrenia, mental retardation, and dysmorphic features: further support for a putative schizophrenia-susceptibility locus at 5q21-23.1. Am J Hum Genet 1997; 61:1450-4.
20. Giltay JC, Gerssen-Schoorl KB, Luitse GH, Dauwerse HG. A case of de novo interstitial deletion of chromosome 5(q33q34). Clin Genet 1997; 52:173-6.
21. Courtens W, Tjalma W, Messiaen L, Vamos E, Martin JJ, Van Bogaert E, et al. Prenatal diagnosis of a constitutional interstitial deletion of chromosome 5 (q15q31.1) presenting with features of congenital contractural arachnodactyly. Am J Med Genet 1998; 77:188-97.
22. Raedle J, Friedl W, Engels H, Koenig R, Trojan J, Zeuzem S. A de novo deletion of chromosome 5q causing familial adenomatous polyposis, dysmorphic features, and mild mental retardation. Am J Gastroenterol 2001; 96:3016-20.
23. Herrera L, Kakati S, Gibas L, Pietrzak E, Sandberg AA. Gardner syndrome in a man with an interstitial deletion of 5q. Am J Med Genet 1986; 25:473-6.
24. Hockey KA, Mulcahy MT, Montgomery P, Levitt S. Deletion of chromosome 5q and familial adenomatous polyposis. J Med Genet 1989; 26:61-2.
25. Kobayashi T, Narahara K, Yokoyama Y, Ueyama S, Mohri O, Fujii T, et al. Gardner syndrome in a boy with interstitial deletion of the long arm of chromosome 5. Am J Med Genet 1991; 41:460-3.
26. Olschwang S, Tiret A, Laurent-Puig P, Muleris M, Parc R, Thomas G. Restriction of ocular fundus lesions to a specific subgroup of APC mutations in adenomatous polyposis coli patients. Cell 1993; 75:959-68.
27. Pilarski RT, Brothman AR, Benn P, Shulman Rosengren S. Attenuated familial adenomatous polyposis in a man with an interstitial deletion of chromosome arm 5q. Am J Med Genet 1999; 86:321-4.
28. Nieuwenhuis MH, Mathus-Vliegen EM, Baeten CG, Nagengast FM, van der Bijl J, van Dalsen AD, et al. Evaluation of management of desmoid tumours associated with familial adenomatous polyposis in Dutch patients. Br J Cancer 2011; 104:37-42.
29. Nieuwenhuis MH, Lefevre JH, Bülow S, Järvinen H, Bertario L, Kernéis S, et al. Family history, surgery, and APC mutation are risk factors for desmoid tumors in familial adenomatous polyposis: an international cohort study. Dis Colon Rectum 2011; 54:1229-34.
30. Colombo C, Foo WC, Whiting D, Young ED, Lusby K, Pollock RE, et al. FAP-related desmoid tumors: a series of 44 patients evaluated in a cancer referral center. Histol Histopathol 2012; 27:641-9.
31. Francis WP, Zippel D, Mack LA, DiFrancesco LM, Kurien E, Schachar NS, et al. Desmoids: a revelation in biology and treatment. Ann Surg Oncol 2009; 16:1650-4.
32. Keus RB, Nout RA, Blay JY, de Jong JM, Hennig I, Saran F, et al. Results of a phase II plot study of moderate dose radiotherapy for inoperable desmoid-type fibromatosis-an EORTC STBSG and ROG study (EORTC62991-22998). Ann Oncol 2013; 24:2672-8.